| Subject: | FDA Safety Precautions for Huber Needles |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Fri, 5 Mar 2010 - 10:00 am |
| The Food and Drug Administration (FDA) is alerting healthcare professionals about safety precautions to be used with Huber needles, used to access ports implanted in chronically ill patients to withdraw blood and infuse medication and other solutions.According to the FDA Huber needles should be designed to penetrate a port without cutting or dislodging any silicone slivers or cores from the port. Coring can damage a port and cause leakage. In addition, if a silicone core enters a patient's... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
|
|
StayAlert! notifies healthcare customers of all federal and regulatory body legislation changes impacting the healthcare industry, including TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others. StayAlert! complements this with regulatory implementation action plans. StayAlert! serves as a virtual healthcare department, augmenting traditional employee staffed departments and freeing employees to perform other vital functions. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|